Mazdutide

10mg · Lyophilized Powder

Mazdutide (IBI362) is a dual GLP-1 receptor and glucagon receptor (GCGR) co-agonist developed by Innovent Biologics, studied for its combined effects on energy balance through complementary pathways. While GLP-1 agonism reduces appetite and improves glucose homeostasis, GCGR activation increases hepatic glucose output and thermogenesis — together producing a distinct metabolic profile from pure GLP-1 agents. Phase 2 and Phase 3 GLORY trial data demonstrate significant weight reduction and glycaemic improvement in subjects with obesity and type 2 diabetes.

All products sold by JA Performance Peptides are intended strictly for laboratory research purposes and are not approved for human consumption, veterinary use, or therapeutic application. Not for human use.